Solarea Bio, a US-based biotechnology focused on developing solutions to improve human health by harnessing the edible plant microbiome, announced on Wednesday that it has named Ilissa Larimore as its new chief commercial officer (CCO).

In the new role, Larimore will manage all commercial activities, driving the strategy for sales, marketing, practitioner partnerships and industry partnerships. She will focus on advancing new products to market, leveraging the company's innovative technology platform, with a particular concentration on medical foods.

Larimore has more than 20 years of experience in consumer health, personalised wellness and practitioner engagement to help individuals achieve optimal health. She has served as a sales representative with Pfizer and Metagenics.

Dr Gerardo V Toledo, Solarea Bio CEO and co-founder, said, 'We are thrilled to welcome Ilissa Larimore to the Solarea Bio team. Her extensive experience in commercial strategy and her passion for leveraging nutrition and medical foods to improve human health make her an invaluable addition to our leadership team. We are confident that Ilissa will play a key role in driving our commercial success and expanding our impact in the market.'